Ming-Yu Lien
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Tislelizumab Combined With Chemoradiotherapy and Surgery for Unresectable Esophageal Squamous Cell Carcinoma (NCT07039162) | Ming-Yu Lien | 2025-09-26 |
Track Ming-Yu Lien automatically
Every clearance here is in the API, with alerts when new ones post.